|
FY2021
10 months to Dec 31, 2021
|
|
|---|---|
| Cash flows from operating activities: | |
| Net income | |
| Warrant related issuance costs | |
| Dividends earned on investment held in the Trust | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | |
| Accrued liabilities | |
| Warrant liabilities | |
| Over-allotment liabilities | |
| Net cash used in operating activities | |
| Cash flows from investing activities: | |
| Cash deposited into trust account | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Sale of units in public offering, net | |
| Sale of warrants in private offering | |
| Proceeds from issuance of Class B ordinary shares to Sponsor | |
| Proceeds from Sponsor note | |
| Repayment of Sponsor note | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash at end of period | |
| Non-cash financing activities: | |
| Initial classification of potentially redeemable ordinary shares | |
| Deferred underwriters' fees | |
| Initial classification of warrant liabilities | |
| Initial classification of over-allotment liabilities | |
| Remeasurement of Class A ordinary shares subject to redemption |
Loading...
